Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD

Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2019.00229
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Using Viral Dynamics to Connect Clinical Markers of Disease Progression to Sequence Evolution During HIV Infection

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2014English

Alcohol Consumption and Markers of Inflammation in Women With Preclinical Rheumatoid Arthritis

Arthritis & Rheumatism
2010English

Intracardiac and Extracardiac Markers of Inflammation During Atrial Fibrillation

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2010English

Clinical Markers to Predict Progression From Acute to Chronic Kidney Disease in Mesoamerican Nephropathy

Kidney International
Nephrology
2018English

Exosomes in HNSCC Plasma as Surrogate Markers of Tumour Progression and Immune Competence

Clinical and Experimental Immunology
AllergyImmunology
2018English

Cerebrospinal Fluid Levels of Inflammation, Oxidative Stress and NAD+ Are Linked to Differences in Plasma Carotenoid Concentrations

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Prm115 - Modeling Decline in Cognition to Decline in Function in Alzheimer’s Disease (Ad)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Predict Cognitive Decline With Clinical Markers in Parkinson’s Disease (PRECODE-1)

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2019English

Relation of Plasma Homocysteine Levels to Atherosclerotic Vascular Disease and Inflammation Markers in Type 2 Diabetic Patients

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy